Author:
Wang Ying,Yuan Zhigang,You Caiyun,Han Jindong,Li Haiyan,Zhang Zhuhong,Yan Hua
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference35 articles.
1. Sadaka A, Giuliari GP: Proliferative vitreoretinopathy: current and emerging treatments. Clin ophtalmol. 2012, 6: 1325-1333.
2. Cunningham MA, Tarantola RM, Folk JC, Sohn EH, Boldt HC, Graff JA, Elkins K, Russell SR, Mahajan VB: Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases. Retina. 2013, 33: 579-585. 10.1097/IAE.0b013e31826b0c41.
3. Fillies T, Woltering M, Brandt B, Van Diest JP, Werkmeister R, Joos U, Buerger H: Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas. Oncol Rep. 2007, 17: 355-359.
4. Fischer PM, Gianella-Borradori A: CDK inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs. 2003, 12: 955-970. 10.1517/13543784.12.6.955.
5. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E: Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell. 1995, 6: 387-400. 10.1091/mbc.6.4.387.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献